Panayotis Thanos PhD

Panayotis Thanos
PhD

Senior Research Scientist (Tenured), Research professor

Department of Pharmacology and Toxicology

Jacobs School of Medicine & Biomedical Sciences

Specialty/Research Focus

Addictions; Ageing; Autism; Behavioral Neuroscience; Behavioral pharmacology; Biomedical Imaging; Blood-Brain Barrier and Drug Delivery; Brain Research; Drug Abuse; Drug Development; Epigenetics; Ethanol Pharmacology; Gene Expression; Gene Therapy; Image Processing and Analysis; Imaging In Vivo; Inflammation; Metabolism; Models - cell and animal; Molecular Basis of Disease; Molecular Imaging Techniques; Neurobiology; Neuroimaging Analysis; Neuropharmacology; Neuropsychiatric Disorders; Neuroscience; Team Science; Translational imaging; Translational Research

Contact Information

1021 Main Street
Clinical Research Institute on Addictions
Department of Pharmacology & Toxicology, Jacobs Schhol of Medicine and Biomedical Sciences, Universi
Buffalo, New York 14203
Phone: 716-881-7520
Fax: 716-881-7520
thanos@buffalo.edu

View map

View faculty website

Overview Research Publications Activities Latest News

Professional Summary:

Research in my laboratory is focused upon distinct projects in the fields of Behavioral Neuropharmacology and Neuroimaging of Addiction and Substance Abuse. Our research is based on the notion that there are specific genetic and epigenetic vulnerabilities that significantly contribute to Reward Deficiency Syndrome (RDS) of which addiction is a part of.
My lab utilizes molecular, behavioral, and imaging (Positron Emission Tomography, MRI, CT, Autoradiograpjy) methods in animal models as well as how these models contribute to clinical data as part of several ongoing clinical translational studies.

Education and Training:

Fellowship, Neuroscience and Neuroimaging of Drug Addiction, SUNY Stony Brook University (2000)
PhD, Biomedical Sciences / Neuroscience, Eastern Virginia Medical School / Old Dominion Unversity (1997)
MA, Biological Psychology, American University (1993)
BS, Psychology, Queen's University (1990)

Employment:

Senior Research Scientist, Department of Pharmacology & Toxicology, Jacobs School of Medicine and Biomedical Sciences, Department of Psychology, Clinical Research Institute on Addictions, University at Buffalo Jacobs School of Medicine & Biomedical Sciences

Awards and Honors:

Award (2025)
Investigator Travel Award (2015)
Investigator Travel Award, RDS (2015)
Investigator Travel Award, Imaging of Alcoholism. NIAAA (2006)
US Department of Energy Science Mentor Award (2003)
PSA Investigator Scholarship Award (1996)
The Ralph D. Millard, M.D. Investigator Award. (1995)
PSA Investigator Scholarship Award (1994)
Press Interview
Massey Foundation Award

Research Expertise:

Behavioral Neuropharmacology and Neuroimaging in Neurological and Psychiatric Disease: Dr. Thanos’ current research includes five major areas: (1) human and animal models to study the underlying genetic and neural mechanisms of the brains reward signaling in obesity and following GLP1 or bariatric surgery; (2) Determining the chronic effects of psychostimulant drugs on brain chemistry, and functional connectivity as well as skeletal development and behavior (3) Understand the role of endocannabinoid signaling and function on pain and reward. (4) Role of prescribed precision exercise on brain reward and therapeutic treatment of neurological disease. (5) Understanding the long-term impact of prenatal exposure to nicotine and cannabis on offspring. 6) Impact of Cannabis on brain reward signaling development and aging.

Grants and Sponsored Research:

February 2022–August 2025
Prenatal Tobacco and Cannabis Exposure: A Translational Study
NIH
Role: Principal Investigator
October 2018–September 2023
Prenatal Tobacco and Cannabis Exposure: A Translational Study
NIDA
Role: Co-Principal Investigator
$690,000
February 2022–January 2023
Response to cocaine following treatment with methylphenidate and fluoxetine.
NIH
Role: Co-Investigator
$60,000
February 2022–February 2022
Genetic and Psychosocial Risks of recidivism and alcohol abuse following bariatric surgery
Blue Sky
Role: Co-Principal Investigator
$30,000
February 2026–February 2022
Iterative Learning and Automated Modular Platform for Optimum Nonaddictive Analgesic Discovery
NCATS
Role: Co-Investigator
$50,000
March 2018–March 2020
Fatty Acid Binding Protein - Mediated Control of Endocannabinoid Signaling and Drug Addiction
NIDA
Role: Co-Principal Investigator
$250,000
September 2018–August 2019
Gastric Bypass, Brain Activity
NY Research Foundation
Role: Principal Investigator
$30,000
February 2012–February 2019
Skeletal Effects of Methylphenidate
NICHD
Role: Co-Investigator
$440,000
January 2016–January 2019
Increased Vulnerability to alcohol abuse after gastric bypass: Neural mechanisms
NIAAA
Role: Principal Investigator
$250,000
June 2014–May 2018
Combined Cocaine and HIV Vaccine
NIDA
Role: Co-Investigator
$163,300
July 2013–July 2015
The Dopamine Reward Circuit Activation Similarities between Food and Addiction
SUNYProvost
Role: Principal Investigator
$264,000

See all (1 more)

Journal Articles:

Roeder NM, Penman SL, Richardson BJ, Wang J, Freeman-Striegel L, Pareek O, Eiden R, Chakraborty S, Thanos PK. (2025) Nicotine e-cigarette exposure in utero diminishes spatial memory and has negative effects on attention in a dose-, diet- and sex-dependent manner. Pharmacology, biochemistry, and behavior (Dec), 257: 174102.
Lantry AM, Lu H, Marion M, Hamilton J, Richardson B, Quattrin T, Mastrandrea LD, Hadjiargyrou M, Komatsu D, Thanos PK. (2025) Combined chronic oral methylphenidate and fluoxetine treatment increases CB1 receptor density in the somatosensory forelimb region. Neuroscience letters (Dec), 869: 138407.
Lewandrowski KU, Lorio MP, Elman I, Blum K, Pinhasov A, Thanos PK, Schmidt SL, Fiorelli RKA. (2025) Prehabilitation Reimagined as Policy: A Multidimensional Framework to Reduce Pain, Opioid Use, and Surgical Risk. International journal of spine surgery (Dec), 19(S3): S30-S47.
Roeser J, Lu H, Lantry AM, Hoerner C, Lagamjis G, Klein S, Ahmed R, Elman I, Pinhasov A, Blum K, Hadjiargyrou M, Komatsu DE, Thanos PK. (2025) Chronic Combined Oral Methylphenidate and Fluoxetine Increases Inflammation in Somatosensory and Mesolimbic Brain Regions. Neurochemical research (Nov), 50(6): 352.
Sharafshah A, Blum K, Lewandrowski KU, Elman I, Fuehrlein BS, Baron D, Pinhasov A, Thanos PK, Fiorelli RKA, Schmidt SL, Gardner EL, Lorio MP, Lewandrowski APL, Gold MS. (2025) Pharmacoepigenomics in Personalized Medicine: A Hypothesis-Generating Approach to Introduce CpG-PGx SNPs as New Candidates for a Systematic Insight into Genomic-Epigenomic-Phenomic-Pharmacogenomics (G-E-Ph-PGx) Axis. Journal of personalized medicine (Nov), 15(12).
Yu C, Tyler JR, Elman I, Blum K, Lewandrowski KU, Sharafshah A, Gold MS, Pinhasov A, Thanos PK. (2025) Exercise-driven modulation of glutamatergic signaling: mechanisms and clinical implications. Neuroscience (Nov), 589: 33-49.
Blum K, Sharafshah A, Khalsa J, Lewandrowski KU, Thanos PK, Lindeau M, Dowling Á, Dowling R, Bergamaschi JP, Pinhasov A, Baron D, Dennen CA, Morgan JP, Elman I, Gardner EL, Gold MS, Modestino EJ, Brian F, Carney PR, Cortese R, Bowirrat A, Sunder K, Mohankumar K, Zeine F, Jafari N, Makale MT, Bagchi D, Ceccanti M, Fiorelli RKA, Schimidt SL, Sipple D, Lewandrowski APL, Matare G, Mahajan S, Mahajan Y, Fliegelman C, Hanna C, Badgaiyan RD. (2025) Computational GWAS Meta Meta Analysis Revealing Cross Talk Between Cannabis CNR1 and DRD2 Receptors Optimizing Long-Term Outcomes for Cannabis Use Disorder (CUD) By Enhancing Dopamine Homeostasis Promoting High-Quality Cannabis Medicinals. Research square (Nov).
Penman SL, Marion M, Hamilton J, Clouse G, Roeder NM, Owada Y, Kagawa Y, Thanos PK. (2025) Fatty acid binding proteins 5 and 7 differentially modulate phenotypic response to acute ?9-tetrahydrocannabinol in female mice. Physiology & behavior (Oct), 299: 114999.
Sharafshah A, Thanos PK, Pinhasov A, Bowirrat A, Hanna C, Lewandrowski KU, Rowan C, Elman I, Gold MS, Dennen CA, Modestino EJ, Badgaiyan RD, Baron D, Fuehrlein B, Gupta A, Cadet JL, Pollack AR, Khalsa J, Makale M, Lewandrowski AP, Blum K. (2025) PGx-Based in silico Analyses Identifies the Interactive Role of Genes, Glucose Metabolism and Dopaminergic Dysfunctional Pathways with Chronic Cocaine use and Misuse. Current neuropharmacology (Sep).
Lewandrowski KU, Alvim Fiorelli RK, Schmidt S, Sharafshah A, Baron D, Gold MS, Thanos PK, Elman I, Bagchi D, Bowirrat A, Pinhasov A, Lorio MP, Blum K. (2025) Opioid-Induced Hyperalgesia and Inflammaging in the Management of Spine Pain: The Case for Genetically Directed Dopamine Homeostasis. International journal of spine surgery (Sep), 19(4): 459-484.
Mari M, Bagaev A, Sur D, Rocha BGS, Begmatova D, Zemliana N, Bowirrat A, Blum K, Thanos PK, Kogan NM, Pinhasov A. (2025) Personality-based intergenerational effects of prenatal THC exposure in an inherited mouse model of social dominance and submissiveness. Scientific reports (Aug), 15(1): 30624.
Sharafshah A, Motovali-Bashi M, Blum K, Lewandrowski KU, Gold MS, Keshavarz P, Thanos PK. (2025) A GWAS Meta-meta-analysis and In-depth Silico Pharmacogenomic Investigations in Identification of APOE and Other Genes Associated with Pain, Anti-inflammatory, and Immunomodulating Agents in Opioid Use Disorder (OUD) Derived from 14.91 M Subjects. Cellular and molecular neurobiology (Jul), 45(1): 76.
Blum K, Mohankumar K, Bagchi D, Lewandrowski KU, Sharafshah A, Elman I, Gold MS, Dennen CA, Thanos PK, Pinhasov A, Bowirrat A, Lewandrowski AP, Baron D, Modestino EJ, Fuehrlein B, Khalsa J, Gastelu D, Fliegelman C, Sunder K, Murphy KT, Makale M, Madigan MA, Lindenau M, Swaroop A, Badgaiyan RD. (2025) Multi-Locus Pro-Dopaminergic Restoration of Reward Brain Circuitry in Reward Deficiency Rescinds Mono-Pharmaceutical Targeting. Neurology (E-Cronicon) (Jul), 17(7).
Bagaev A, Sur D, Agranyoni O, Pe'er N, Savita BK, Rocha BGS, Thanos PK, Navon-Venezia S, Pinhasov A. (2025) Maternal oral sodium propionate supplementation restores gut integrity and mitigates stress-induced metabolic and behavioral outcomes in offspring. Translational psychiatry (Jul), 15(1): 235.
Lagamjis G, Lu H, Roeder NM, Richardson BJ, Marion M, Quattrin T, Mastrandrea LD, Hadjiargyrou M, Komatsu DE, Thanos PK. (2025) Combined Chronic Oral Methylphenidate and Fluoxetine Decreases D2R Levels in the Caudate Putamen and Nucleus Accumbens. Neurochemical research (Jul), 50(4): 230.
Powell A, Yamaguchi N, Lu H, Pareek O, Elman I, Gold MS, Pinhasov A, Blum K, Thanos PK. (2025) The Role of Fatty Acid Binding Proteins in Neuropsychiatric Diseases: A Narrative Review. Frontiers in bioscience (Landmark edition) (Jun), 30(6): 26812.
Bobick M, Hanna C, Tyler J, Mohr P, Lu H, Powell A, Blum K, Baron D, Lewandrowski KU, Elman I, Pinhasov A, Gold MS, Thanos PK. (2025) Exercise Leads to Brain Glucose Metabolism Activation, Increased Dopamine D1 Receptor Levels and is Negatively Correlated with Social Behavior. Journal of integrative neuroscience (Jun), 24(6): 36646.
Blum K, Braverman ER, Sharafshah A, Elman I, Lewandrowski KU, Bowirrat A, Pinhasov A, Thanos PK, Gold MS, Dennen CA, Modestino EJ, Badgaiyan RD, Baron D, Fuehrlein B, Sipple D, Ashford JW, Sunder K, Makale M, Murphy K, Jafari N, Zeine F, Pollack AR, Lewandrowski APL, Khalsa J. (2025) Exploring dopamine as the master regulator of brain circuitry and mental health genome. Gene & protein in disease (Jun), 5.
Lotosky J, Jean X, Altankhuyag A, Khan S, Bernotas A, Sharafshah A, Blum K, Posner A, Thanos PK. (2025) GLP-1 and Its Role in Glycogen Production: A Narrative Review. Biomedicines (Jun), 13(7).
Tyler J, Park Y, Lu H, Roeder N, Richardson B, Gold MS, Blum K, Pinhasov A, Baron D, Thanos PK. (2025) High-intensity interval training exercise decreases brain CB1 receptor levels in male and female adult rats. Neuroscience (May), 573: 254-263.
Blum K, Sharafshah A, -Uwe-Lewandowski K, Pinhasov A, Elman I, Thanos PK, Baron D, Dennen CA, Bowirrat A, Modestino EJ, Gold MS, Lewandowski AP, Fliegelman C, Badgaiyan RD. (2025) Is It Scientifically Possible To 'Cure" Reward Deficiency Syndrome (RDS) Via Transplice Molecular Genetic Technology?. Acta scientific neurology (Apr), 8(4): 15-20.
Blum K, Lewandowski KU, Sharafshah A, Dennen CA, Pinhasov A, Bowirrat A, Fliegelman C, Bagchi D, Lewandrowski AP, Mahajan S, Thanos PK, Badgaiyan RD. (2025) Theorizing The Role of Gama Type Endorphins in Schizophrenia and Alcoholism: Promoting Genetic Testing and Attempts at Inducing "Dopamine Homeostasis". Acta scientific neurology (Apr), 8(4): 28-40.
Lewandrowski KU, Bowirrat A, Pinhasov A, Sharafshah A, Gold MS, Fuehrlein B, Elman I, Dennen C, Thanos PK, Hanna C, Sipple D, Baron D, Martire G, Modestino EJ, Jafari N, Zeine F, Sunder K, Lewandrowski AP, Badgaiyan RD, Khalsa J, Pollack A, Fiorelli RKA, Schmidt S, Fliegelman C, Lorio MP, Makale MT, Blum K. (2025) Dopaminergic Homeostatic Therapy (DHT™) as a Putative Anti-Addiction Seeking Intervention and Early Identification of Genetic Preaddiction with Genetic Addiction Risk Severity (GARS®) Screening. Acta scientific neurology (Apr), 8(5): 70-88.
Lewandrowski KU, Blum K, Sharafshah A, Thanos KZ, Thanos PK, Zirath R, Pinhasov A, Bowirrat A, Jafari N, Zeine F, Makale M, Hanna C, Baron D, Elman I, Modestino EJ, Badgaiyan RD, Sunder K, Murphy KT, Gupta A, Lewandrowski APL, Fiorelli RKA, Schmidt S. (2025) Genetic and Regulatory Mechanisms of Comorbidity of Anxiety, Depression and ADHD: A GWAS Meta-Meta-Analysis Through the Lens of a System Biological and Pharmacogenomic Perspective in 18.5 M Subjects. Journal of personalized medicine (Mar), 15(3).
Sharafshah A, Lewandrowski KU, Elman I, Baron D, Thanos PK, Hanna C, Gold MS, Badgaiyan RD, Cadet JL, Modestino EJ, Braverman ER, Dennen CA, Makale M, Sunder K, Murphy KT, Bowirrat A, Pinhasov A, Gondre-Lewis M, Gardner E, Sipple D, Jafari N, Zeine F, Khalsa J, Fiorelli RKA, Blum K. (2025) A Comprehensive 4-layered In Silico Pharmacogenomics Analysis of the Genetic Addiction Risk Severity (GARS) Test: Strong Genetic Evidence Supporting GARS as a Novel Personalized Pre-addiction Assessment Tool in the Opioid Crisis Era. Current pharmaceutical biotechnology (Jan), 26(13): 2153-2180.
Hanna C, Comstock F, Chatrath S, Posner A, Butsch J, Blum K, Gold MS, Georger L, Mastrandrea LD, Quattrin T, Thanos PK. (2025) Utilization of a precision medicine genetic and psychosocial approach in outcome assessment of bariatric weight loss surgery: a narrative review. Frontiers in public health (Jan), 13: 1516122.
Rowan C, Hanna C, Sajjad M, Yao R, Sharafsha A, Lewandrowski KU, Blum K, Pinhasov A, Thanos PK. (2025) Cocaine self-administration attenuates brain glucose metabolism and functional connectivity in rats. PloS one (Jan), 20(6): e0324522.
Sharafshah A, Lewandrowski KU, Gold MS, Fuehrlein B, Ashford JW, Thanos PK, Wang GJ, Hanna C, Cadet JL, Gardner EL, Khalsa JH, Braverman ER, Baron D, Elman I, Dennen CA, Bowirrat A, Pinhasov A, Modestino EJ, Carney PR, Cortese R, Fiorelli RKA, Schmidt S, Pollack AR, Badgaiyan RD, Blum K. (2025) In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide Ideation and Substance Use Disorder. Current neuropharmacology (Jan).
Lu H, Roeder N, Richardson B, Hamilton J, Sharma A, Owada Y, Kagawa Y, Thanos P. (2025) Fatty acid-binding protein 7 gene deletion promotes decreases in brain cannabinoid type 1 receptor binding. Neuroscience letters (Jan), 844: 138040.
Sunder K, Makale MT, Makale M, Bodhanapati J, Murphy KT, Dennen CA, Baron D, Thanos PK, Hanna C, Ashford JW, Lewandrowski KU, Blum K. (2025) Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) as Demonstrated by PHQ-9 and GAD-7: Pilot Case Series. Psychology research and behavior management (Jan), 18: 225-240. doi:10.2147/PRBM.S482960
Blum K, Sharafshah A, Khalsa J, Uwe-Lewandrowski K, Mohankumar K, Thanos PK, Pinhasov A, Baron D, Dennen CA, Morgan JJ, Lindenau M, Elman I, Gardner EL, Gold MS, Modestino EJ, Brian F, Carney PR, Cortese R, Bowirrat A, Madigan MA, Sunder K, Lorio MP, Zeine F, Jafari N, Makale MT, Bagchi D, Ceccanti M, Fiorelli RKA, Schimidt SL, Sipple D, Lewandrowski APL, Matare G, Mahajan S, Mahajan Y, Hanna C, Gastelu D, Swaroop A, Fliegelman C, Badgaiyan RD. (2025) Precision Genomics: A Reality Having Universal Impact in a New Era of Psychiatry - Lessons Learned, Past and Present. Journal of addiction psychiatry (Jan), 9(1): 8-13.
Hammond N, Rahman N, Zhan S, Gold MS, Blum K, Quattrin T, Yim YY, Nestler EJ, Thanos PK. (2025) Chronic High Intensity Interval Training (HIIT) exercise in adolescent rats results in cocaine place aversion and ?FosB induction. PloS one (Jan), 20(9): e0316228.
Lewandrowski KU, Blum K, Lewandrowski APL, Thanos PK, Pinhasov A, Sharafshah A, Baron D, Gold MS, Dennen CA, Elman I, Bowirrat A, Modestino EJ, Zeine F, Jafari N, Sunder K, Makale MT, Giordano J, Gondre-Lewis MC, Lindenau M, Fuehrlein BS, Badgaiyan RD, Levin C, Schmidt SL, Fiorelli RKA. (2025) Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia. Frontiers in public health (Jan), 13: 1594872.
Oleszak K, Striegel LF, Roeder N, Mohr P, Penman S, Collins L, Smith DM, Thanos PK. (2025) The Effects of THC and Nicotine on Attention: A Narrative Review. Current topics in behavioral neurosciences (Jan), 75: 183-238.
Blum K, Bowirrat A, Thanos PK, Hanna C, Khalsa J, Baron D, Elman I, Badgaiyan RD, Dennen C, Braverman ER, Carney P, Lewandrowski KU, Sharafshah A, Gold MS. (2024) Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in Preaddiction. EC psychology and psychiatry (Dec), 13(1): 1-3.
Hrabak M, Ahmed R, Soriano MG, Powell A, Thanos PK, Steiner H. (2024) Vilazodone, a Novel SSRI Antidepressant with 5-HT1A Partial Agonist Properties: Diminished Potentiation of Chronic Oral Methylphenidate-Induced Dynorphin Expression in the Striatum in Adolescent Male Rats. Molecular neurobiology (Oct).
Collins RL, Thanos PK, Ashare R, Herzberg D, Silverman R. (2024) Effects of the Federal Government's Move to Reschedule Cannabis: A Commentary. Journal of studies on alcohol and drugs (Oct).
Penman SL, Roeder NM, Wang J, Richardson BJ, Freeman-Striegel L, Krayevsky A, Eiden RD, Chakraborty S, Thanos PK. (2024) Vaporized ?9-tetrahydrocannabinol exposure in utero has negative effects on attention in a dose- and sex-dependent manner. Pharmacology, biochemistry, and behavior (Sep), 242: 173808.
Penman SL, Roeder NM, Wang J, Richardson BJ, Pareek O, Freeman-Striegel L, Mohr P, Khan A, Eiden RD, Chakraborty S, Thanos PK. (2024) Vaporized nicotine in utero results in reduced birthweight, increased locomotion, and decreased voluntary exercise, dependent on sex and diet in offspring. Psychopharmacology (Sep), 241(9): 1857-1882.
Blum K, Elman I, Han D, Hanna C, Baron D, Gupta A, Kazmi S, Khalsa J, Bagchi D, McLaughlin T, Badgaiyan RD, Modestino EJ, Edwards D, Dennen CA, Braverman ER, Bowirrat A, Sunder K, Murphy K, Jafari N, Zeine F, Carney PR, Gold MS, Lewandowski KU, Sharafshah A, Pollack AR, Thanos PK. (2024) The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies. Open journal of immunology (Sep), 14(3): 60-86. doi:10.4236/oji.2024.143006
Blum K, Mclaughlin T, Lewandrowski KU, Sharafshah A, Dennen C, Thanos PK, Baron D, Modestino EJ, Sunder K, Murphy KT, Makle M, Giley E, Braverman ER, Giordano J, Badgaiyan RD. (2024) Complex NADASE Infusions Improve Clinical Outcome in Substance Use Disorder: Descriptive Annotation in Fifty Cases. Journal of addiction psychiatry (Aug), 8(1): 95-157.
Nowak J, Aronin J, Beg F, O'Malley N, Ferrick M, Quattrin T, Pavlesen S, Hadjiargyrou M, Komatsu DE, Thanos PK. (2024) The Effects of Chronic Psychostimulant Administration on Bone Health: A Review. Biomedicines (Aug), 12(8). doi:10.3390/biomedicines12081914
Blum K, Bowirrat A, Sunder K, Thanos PK, Hanna C, Gold MS, Dennen CA, Elman I, Murphy KT, Makale MT. (2024) Dopamine Dysregulation in Reward and Autism Spectrum Disorder. Brain sciences (Jul), 14(7). doi:10.3390/brainsci14070733
Khan A, Richardson B, Roeder N, Hamilton J, Marion M, Fearby N, White O, Owada Y, Kagawa Y, Thanos PK. (2024) The role of fatty acid-binding protein 5 and 7 on locomotor, anxiety and social behavior: Interaction with NMDA signaling. Neuroscience letters (Jul), 836: 137862.
Ortiz LM, O'Malley N, Blum K, Hadjiargyrou M, Komatsu DE, Thanos PK. (2024) Psychostimulants prescribed to children for ADHD following distal radius fractures significantly reduce bone density as a function of duration. Journal of pediatric orthopedics. Part B (Jul), 33(4): 399-406.
Roeder NM, Mihalkovic A, Richardson BJ, Penman SL, Novalen M, Hammond N, Eiden R, Khokhar JY, Tyndale RF, Thanos PK. (2024) Behavioral and Pharmacokinetic Assessment of Nicotine e-Cigarette Inhalation in Female Rats. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco (May), 26(6): 724-732. doi:10.1093/ntr/ntad240
Mohr P, Hanna C, Powell A, Penman S, Blum K, Sharafshah A, Lewandrowski KU, Badgaiyan RD, Bowirrat A, Pinhasov A, Thanos PK. (2024) Selenoprotein P in a Rodent Model of Exercise; Theorizing Its Interaction with Brain Reward Dysregulation, Addictive Behavior, and Aging. Journal of personalized medicine (May), 14(5). doi:10.3390/jpm14050489
Powell A, Hanna C, Sajjad M, Yao R, Blum K, Gold MS, Quattrin T, Thanos PK. (2024) Exercise Influences the Brain's Metabolic Response to Chronic Cocaine Exposure in Male Rats. Journal of personalized medicine (May), 14(5). doi:10.3390/jpm14050500
Modestino EJ, Bowirrat A, Lewandrowski KU, Sharafshah A, Badgaiyan RD, Thanos PK, Baron D, Dennen CA, Elman I, Sunder K, Murphy KT, Blum K. (2024) Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss. Acta scientific neurology (May), 7(5): 12-18. doi:10.31080/asne.2024.07.0731
Blum K, Braverman ER, Gold MS, Dennen CA, Baron D, Thanos PK, Hanna C, Elman I, Gondre-Lewis MC, Ashford JW, Newberg A, Madigan MA, Jafari N, Zeine F, Sunder K, Giordano J, Barh D, Gupta A, Carney P, Bowirrat A, Badgaiyan RD. (2024) Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development. INNOSC theranostics & pharmacological sciences (Apr), 7(2): 1472. doi:10.36922/itps.1472
Blum K, Bowirrat A, Baron D, Elman I, Makale MT, Cadet JL, Thanos PK, Hanna C, Ahmed R, Gondre-Lewis MC, Dennen CA, Braverman ER, Soni D, Carney P, Khalsa J, Modestino EJ, Barh D, Bagchi D, Badgaiyan RD, McLaughlin T, Cortese R, Ceccanti M, Murphy KT, Gupta A, Makale MT, Sunder K, Gold MS. (2024) Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences. Gene & protein in disease (Mar), 3(1). doi:10.36922/gpd.1966
Roeder NM, Penman SL, Richardson BJ, Wang J, Freeman-Striegel L, Khan A, Pareek O, Weiss M, Mohr P, Eiden RD, Chakraborty S, Thanos PK. (2024) Vaporized ?9-THC in utero results in reduced birthweight, increased locomotion, and altered wake-cycle activity dependent on dose, sex, and diet in the offspring. Life sciences (Mar), 340: 122447.
Ahmed R, Zyla S, Hammond N, Blum K, Thanos PK. (2024) The Role of Estrogen Signaling and Exercise in Drug Abuse: A Review. Clinics and practice (Jan), 14(1): 148-163. doi:10.3390/clinpract14010012
Miller G, Pareek O, Penman SL, Thanos PK. (2024) The Effects of Nicotine and Cannabinoids on Cytokines. Current pharmaceutical design (Jan), 30(31): 2468-2484.
Gold MS, Blum K, Bowirrat A, Pinhasov A, Bagchi D, Dennen CA, Thanos PK, Hanna C, Lewandrowski KU, Sharafshah A, Elman I, Badgaiyan RD. (2024) A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence. INNOSC theranostics & pharmacological sciences (Jan), 7(3). doi:10.36922/itps.1918
Klein SR, Blum K, Gold MS, Thanos PK. (2024) Chronic Methylphenidate Effects on Brain Gene Expression: An Exploratory Review. Psychology research and behavior management (Jan), 17: 577-592. doi:10.2147/PRBM.S445719
Shisler S, Lee JK, Schlienz NJ, Hawk LW, Thanos PK, Kong KL, Leising MC, Eiden RD. (2024) Prenatal tobacco and tobacco-cannabis co-exposure: Relationship with attention and memory in middle childhood. Neurotoxicology and teratology (Jan), 104: 107371.
Sedhom S, Hammond N, Thanos KZ, Blum K, Elman I, Bowirrat A, Dennen CA, Thanos PK. (2024) Potential Link Between Exercise and N-Methyl-D-Aspartate Glutamate Receptors in Alcohol Use Disorder: Implications for Therapeutic Strategies. Psychology research and behavior management (Jan), 17: 2363-2376. doi:10.2147/PRBM.S462403
Zeine F, Jafari N, Baron D, Bowirrat A, Pinhasov A, Norling B, Martinez KC, Nami M, Manavi N, Sunder K, Rabin DM, Bagchi D, Khalsa J, Gold MS, Sipple D, Barzegar M, Bodhanapati J, Khader W, Carney P, Dennen CA, Gupta A, Elman I, Badgaiyan RD, Modestino EJ, Thanos PK, Hanna C, McLaughlin T, Cadet JL, Soni D, Braverman ER, Barh D, Giordano J, Edwards D, Ashford JW, Gondre-Lewis MC, Gilley E, Murphy KT, Lewandrowski KU, Sharafshah A, Makale M, Fuehrlein B, Blum K. (2024) Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy. Journal of addiction psychiatry (Jan), 8(1): 50-95.
Martire G, Sipple D, Baron D, Gold MS, Lewandowski KU, Dennen CA, Sharafshah A, Elman I, Thanos PK, Modestino EJ, Badgaiyan RD, Pinhasov A, Bowirrat A, Makale M, Roy AK, Sunder K, Murphy KT, Mahajan S, Mahajan Y, Levin C, Blum K. (2024) Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders. Journal of addiction psychiatry (Jan), 8(2): 161-165.
Penman SL, Senetra AS, Roeder NM, Richardson BJ, Pareek O, Owada Y, Kagawa Y, Gold MS, McCurdy CR, Sharma A, Thanos PK. (2024) Fatty acid binding protein 7 plays an important modulatory sex-dependent role on brain endocannabinoid levels and THC metabolism. PloS one (Jan), 19(12): e0313091. doi:10.1371/journal.pone.0313091
Modestino EJ, Bowirrat A, Baron D, Thanos PK, Hanna C, Bagchi D, Braverman ER, Dennen CA, Badgaiyan RD, Pollack AR, Lewandrowski KU, Sharafshah A, Gold MS, Blum K. (2024) Is There a Natural, Non-addictive, and Non-anti-reward, Safe, Gene-based Solution to Treat Reward Deficiency Syndrome? KB220 Variants vs GLP-1 Analogs. Journal of addiction psychiatry (Jan), 8(1): 34-49.
Senior D, McCarthy M, Ahmed R, Klein S, Lee WX, Hadjiargyrou M, Komatsu D, Steiner H, Thanos PK. (2023) Chronic oral methylphenidate plus fluoxetine treatment in adolescent rats increases cocaine self-administration. Addiction neuroscience (Dec), 8. doi:10.1016/j.addicn.2023.100127
Hanna C, Yao R, Sajjad M, Gold M, Blum K, Thanos PK. (2023) Exercise Modifies the Brain Metabolic Response to Chronic Cocaine Exposure Inhibiting the Stria Terminalis. Brain sciences (Dec), 13(12). doi:10.3390/brainsci13121705
Richardson BJ, Hamilton J, Roeder N, Thanos KZ, Marion M, Thanos PK. (2023) Fatty acid-binding protein 5 differentially impacts dopamine signaling independent of sex and environment. Addiction neuroscience (Dec), 8. doi:10.1016/j.addicn.2023.100118
Penman SL, Roeder NM, Berthold EC, Senetra AS, Marion M, Richardson BJ, White O, Fearby NL, McCurdy CR, Hamilton J, Sharma A, Thanos PK. (2023) FABP5 is important for cognitive function and is an important regulator of the physiological effects and pharmacokinetics of acute ?9 tetrahydrocannabinol inhalation in mice. Pharmacology, biochemistry, and behavior (Oct), 231: 173633.
Blum K, Ashford JW, Kateb B, Sipple D, Braverman E, Dennen CA, Baron D, Badgaiyan R, Elman I, Cadet JL, Thanos PK, Hanna C, Bowirrat A, Modestino EJ, Yamamoto V, Gupta A, McLaughlin T, Makale M, Gold MS. (2023) Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatry. Journal of the neurological sciences (Oct), 453: 120809.
Blum K, Gold MS, Cadet JL, Gondre-Lewis MC, McLaughlin T, Braverman ER, Elman I, Paul Carney B, Cortese R, Abijo T, Bagchi D, Giordano J, Dennen CA, Baron D, Thanos PK, Soni D, Makale MT, Makale M, Murphy KT, Jafari N, Sunder K, Zeine F, Ceccanti M, Bowirrat A, Badgaiyan RD. (2023) Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis. Medical research archives (Sep), 11(8). doi:10.18103/mra.v11i8.4211
Thanos PK, Hanna C, Mihalkovic A, Hoffman A, Posner A, Butsch J, Blum K, Georger L, Mastrandrea LD, Quattrin T. (2023) Genetic Correlates as a Predictor of Bariatric Surgery Outcomes after 1 Year. Biomedicines (Sep), 11(10). doi:10.3390/biomedicines11102644
Makale MT, Nybo C, Keifer J, Blum K, Dennen CA, Baron D, Sunder K, Elman I, Makale MR, Thanos PK, Murphy KT. (2023) Preliminary Observations of Personalized Repetitive Magnetic Stimulation (PrTMS) Guided by EEG Spectra for Concussion. Brain sciences (Aug), 13(8). doi:10.3390/brainsci13081179
Freeman-Striegel L, Hamilton J, Kannappan R, Bell T, Robison L, Thanos PK. (2023) Chronic ?9-tetrahydrocannabinol treatment has dose-dependent effects on open field exploratory behavior and [3H] SR141716A receptor binding in the rat brain. Life sciences (Aug), 327: 121825.
Thanos PK, Hanna C, Mihalkovic A, Hoffman AB, Posner AR, Busch J, Smith C, Badgaiyan RD, Blum K, Baron D, Mastrandrea LD, Quattrin T. (2023) The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical Research. Journal of personalized medicine (Jul), 13(7). doi:10.3390/jpm13071164
Blum K, Bowirrat A, Elman I, Baron D, Thanos PK, Gold MS, Hanna C, Makale MT, Sunder K, Jafari N, Zeine F, Murphy KT, Makale M, Badgaiyan RD. (2023) Evidence for the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS). Clinical and experimental psychology (Jun), 9(4): 8-11.
Kong KL, Lee JK, Shisler S, Thanos PK, Huestis MA, Hawk L, Eiden RD. (2023) Prenatal tobacco and cannabis co-exposure and offspring obesity development from birth to mid-childhood. Pediatric obesity (May), 18(5): e13010. doi:10.1111/ijpo.13010
Roeder N, Richardson B, Mihalkovic A, Penman S, White O, Hamilton J, Gupta A, Blum K, Gold MS, Thanos PK. (2023) Fatty Acid-Binding Protein 5 Gene Deletion Enhances Nicotine-Conditioned Place Preference: Illuminating the Putative Gateway Mechanisms. Future pharmacology (Mar), 3(1): 108-116. doi:10.3390/futurepharmacol3010007
Blum K, Bowirrat A, Braverman ER, Dennen C, Zeine F, Jafari N, Sunder K, Thanos PK, Baron D, Barh D, Gupta A, Bagchi D, Gold MS, Badgaiyan RD. (2023) Beyond Mor: Can Induction of Dopamine Homeostasis Along with Electrotherapy Attenuate the Opioid Crisis?. Clinical and experimental psychology (Mar), 9(2): 1-3.
Senior D, Ahmed R, Arnavut E, Carvalho A, Lee WX, Blum K, Komatsu DE, Hadjiargyrou M, Badgaiyan RD, Thanos PK. (2023) Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review. Journal of personalized medicine (Mar), 13(4). doi:10.3390/jpm13040574
Hamilton J, Nguyen C, McAvoy M, Roeder N, Richardson B, Quattrin T, Hajnal A, Thanos PK. (2023) Calorie restriction, but not Roux-en-Y gastric bypass surgery, increases [3 H] PK11195 binding in a rat model of obesity. Synapse (New York, N.Y.) (Mar), 77(2): e22258.
Blum K, McLaughlin T, Bowirrat A, Bagchi D, Braverman ER, Gupta A, Baron D, Thanos PK, Khalsa J, Jafari N, Zeine F, Giordano J, Dennen CA, Madigan MA, Carney P, Gold MS, Sunder K, Badgaiyan RD. (2023) Futuristic Thinking about Engineering "Geneospirituality" to Help Prevent Relapse of Reward Deficiency Syndrome (RDS) Behaviors. EC psychology and psychiatry (Feb), 12(3): 26-32.
Bajaj A, Han D, Elman I, Thanos PK, Dennen CA, Badgaiyan RD, Bowirrat A, Barh D, Blum K. (2023) Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy-A Case-Series. Journal of personalized medicine (Feb), 13(2). doi:10.3390/jpm13020336
Chirokikh AA, Uddin SMZ, Areikat N, Jones R, Duque E, Connor C, Hadjiargyrou M, Thanos PK, Komatsu DE. (2023) Combined methylphenidate and fluoxetine treatment in adolescent rats significantly impairs weight gain with minimal effects on skeletal development. Bone (Feb), 167: 116637.
Blum K, Green R, Mullen P, Han D, Bowirrat A, Elman I, Floyd JB, Thanos PK, Baron D, Gold MS, Badgaiyan RD. (2023) Reward Deficiency Syndrome Solution System (RDSSS) A Genetically Driven Putative Inducer of "Dopamine Homeostasis" as a Futuristic Alternative to Enhance Rehabilitation Instead of Incarceration. Asian journal of complementary and alternative medicine : A-CAM (Jan), 11(1): 11-14. doi:10.53043/2347-3894.acam11003
Penman SL, Berthold EC, Mihalkovic A, Hammond N, McCurdy CR, Blum K, Eiden RD, Sharma A, Thanos PK. (2023) Vaporized Delta-9-tetrahydrocannabinol Inhalation in Female Sprague Dawley Rats: A Pharmacokinetic and Behavioral Assessment. Current pharmaceutical design (Jan), 29(27): 2149-2160. doi:10.2174/1381612829666230419093809
Ahmed R, Blum K, Thanos PK. (2023) Epigenetic Effects of Psychoactive Drugs. Current pharmaceutical design (Jan), 29(27): 2124-2139.
Blum K, Dennen C, Carney PR, Gilley E, Thanos PK, Braverman ER, Baron D, Hanna C, Modestino EJ, Gold MS, Elman I, Badgaiyan RD. (2023) Psychostimulants for Children: Are We Over or Under Dosing?. Journal of addiction psychiatry (Jan), 7(1): 1-4.
Blum K, Thanos PK, Hanna C, Gold MS, Baron D, Elman I. (2023) "TO BE OR NOT TO BE" GWAS Ends the Controversy about the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS). Psychology research and behavior management (Jan), 16: 4287-4291. doi:10.2147/PRBM.S428841
Bowirrat A, Elman I, Dennen CA, Gondré-Lewis MC, Cadet JL, Khalsa J, Baron D, Soni D, Gold MS, McLaughlin TJ, Bagchi D, Braverman ER, Ceccanti M, Thanos PK, Modestino EJ, Sunder K, Jafari N, Zeine F, Badgaiyan RD, Barh D, Makale M, Murphy KT, Blum K. (2023) Neurogenetics and Epigenetics of Loneliness. Psychology research and behavior management (Jan), 16: 4839-4857. doi:10.2147/PRBM.S423802
Blum K, Mclaughlin T, Gold MS, Gondre-Lewis MC, Thanos PK, Elman I, Baron D, Bowirrat A, Barh D, Khalsa J, Hanna C, Jafari N, Zeine F, Braverman ER, Dennen C, Makale MT, Makale M, Sunder K, Murphy KT, Badgaiyan RD. (2023) Are We Getting High Cause the Thrill is Gone?. Journal of addiction psychiatry (Jan), 7(1): 5-516.
Tyler J, Podaras M, Richardson B, Roeder N, Hammond N, Hamilton J, Blum K, Gold M, Baron DA, Thanos PK. (2023) High intensity interval training exercise increases dopamine D2 levels and modulates brain dopamine signaling. Frontiers in public health (Jan), 11: 1257629. doi:10.3389/fpubh.2023.1257629
Thanos PK, McCarthy M, Senior D, Watts S, Connor C, Hammond N, Blum K, Hadjiargyrou M, Komatsu D, Steiner H. (2023) Combined Chronic Oral Methylphenidate and Fluoxetine Treatment During Adolescence: Effects on Behavior. Current pharmaceutical biotechnology (Jan), 24(10): 1307-1314.
Lee YK, Gold MS, Blum K, Thanos PK, Hanna C, Fuehrlein BS. (2023) Opioid use disorder: current trends and potential treatments. Frontiers in public health (Jan), 11: 1274719. doi:10.3389/fpubh.2023.1274719
Ceccanti M, Blum K, Bowirrat A, Dennen CA, Braverman ER, Baron D, Mclaughlin T, Giordano J, Gupta A, Downs BW, Bagchi D, Barh D, Elman I, Thanos PK, Badgaiyan RD, Edwards D, Gold MS. (2022) Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids. Journal of personalized medicine (Dec), 12(12). doi:10.3390/jpm12122015
Modestino EJ, Blum K, Dennen CA, Downs BW, Bagchi D, Llanos-Gomez L, Elman I, Baron D, Thanos PK, Badgaiyan RD, Braverman ER, Gupta A, Gold MS, Bowirrat A. (2022) Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing. Journal of personalized medicine (Nov), 12(12). doi:10.3390/jpm12121946
Hanna C, Hamilton J, Blum K, Badgaiyan RD, Thanos PK. (2022) Exercise Modulates Brain Glucose Utilization Response to Acute Cocaine. Journal of personalized medicine (Nov), 12(12). doi:10.3390/jpm12121976
Dennen CA, Blum K, Bowirrat A, Thanos PK, Elman I, Ceccanti M, Badgaiyan RD, McLaughlin T, Gupta A, Bajaj A, Baron D, Downs BW, Bagchi D, Gold MS. (2022) Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family. Journal of personalized medicine (Nov), 12(11). doi:10.3390/jpm12111864
Clouse G, Penman S, Hadjiargyrou M, Komatsu DE, Thanos PK. (2022) Examining the role of cannabinoids on osteoporosis: a review. Archives of osteoporosis (Nov), 17(1): 146.
Blum K, Bowirrat A, Gomez LL, Downs BW, Bagchi D, Barh D, Modestino EJ, Baron D, McLaughlin T, Thanos P, Ceccanti M, Elman I, Badgaiyan RD, Dennen C, Gupta A, Braverman ER, Gold MS. (2022) Why haven't we solved the addiction crisis?. Journal of the neurological sciences (Nov), 442: 120404.
Neuman J, Roeder N, Richardson B, Quattrin T, Hamilton J, Thanos PK. (2022) High Fat Diet Increases [3H] Flunitrazepam Binding in the Mouse Brain that is Dependent on the Expression of the Dopamine D2 Gene. Neurochemical research (Oct), 47(10): 3003-3011.
Blum K, Dennen CA, Elman I, Bowirrat A, Thanos PK, Badgaiyan RD, Downs BW, Bagchi D, Baron D, Braverman ER, Gupta A, Green R, McLaughlin T, Barh D, Gold MS. (2022) Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?. Journal of personalized medicine (Oct), 12(10). doi:10.3390/jpm12101719
Blum K, Han D, Bowirrat A, Downs BW, Bagchi D, Thanos PK, Baron D, Braverman ER, Dennen CA, Gupta A, Elman I, Badgaiyan RD, Llanos-Gomez L, Khalsa J, Barh D, McLaughlin T, Gold MS. (2022) Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index. Journal of personalized medicine (Oct), 12(11). doi:10.3390/jpm12111772
Blum K, Dennen CA, Braverman ER, Gupta A, Baron D, Downs BW, Bagchi D, Thanos P, Pollock M, Khalsa J, Elman I, Bowirrat A, Badgaiyan RA. (2022) Hypothesizing That Pediatric Autoimmune Neuropsychiatric Associated Streptococcal (PANDAS) Causes Rapid Onset of Reward Deficiency Syndrome (RDS) Behaviors and May Require Induction of "Dopamine Homeostasis". Open journal of immunology (Sep), 12(3): 65-75. doi:10.4236/oji.2022.123004
White O, Roeder N, Blum K, Eiden RD, Thanos PK. (2022) Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review. International journal of environmental research and public health (Aug), 19(15). doi:10.3390/ijerph19159477
Blum K, Han D, Gupta A, Baron D, Braverman ER, Dennen CA, Kazmi S, Llanos-Gomez L, Badgaiyan RD, Elman I, Thanos PK, Downs BW, Bagchi D, Gondre-Lewis MC, Gold MS, Bowirrat A. (2022) Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case-Control Subjects. Journal of personalized medicine (Aug), 12(9). doi:10.3390/jpm12091385
Rapp C, Hamilton J, Richer K, Sajjad M, Yao R, Thanos PK. (2022) Alcohol binge drinking decreases brain glucose metabolism and functional connectivity in adolescent rats. Metabolic brain disease (Aug), 37(6): 1901-1908.
Arnavut E, Hamilton J, Yao R, Sajjad M, Hadjiargyrou M, Komatsu D, Thanos PK. (2022) Abstinence following intermittent methylphenidate exposure dose-dependently modifies brain glucose metabolism in the rat brain. Synapse (New York, N.Y.) (Aug), 76(9-10): 17-30.
Dennen CA, Blum K, Bowirrat A, Khalsa J, Thanos PK, Baron D, Badgaiyan RD, Gupta A, Braverman ER, Gold MS. (2022) Neurogenetic and Epigenetic Aspects of Cannabinoids. Epigenomes (Aug), 6(3). doi:10.3390/epigenomes6030027
Blum K, Han D, Baron D, Kazmi S, Elman I, Gomez LL, Gondre-Lewis MC, Thanos PK, Braverman ER, Badgaiyan RD. (2022) Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty Cases. Current psychiatry research and reviews (Jul), 18(2): 125-143. doi:10.2174/2666082218666220527114427
Hamilton J, Roeder N, Richardson B, Hammond N, Sajjad M, Yao R, Owada Y, Kagawa Y, Thanos PK. (2022) Unpredictable chronic mild stress differentially impacts resting brain glucose metabolism in fatty acid-binding protein 7 deficient mice. Psychiatry research. Neuroimaging (Jul), 323: 111486.
Blum K, Brodie MS, Pandey SC, Cadet JL, Gupta A, Elman I, Thanos PK, Gondre-Lewis MC, Baron D, Kazmi S, Bowirrat A, Febo M, Badgaiyan RD, Braverman ER, Dennen CA, Gold MS. (2022) Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation. Journal of personalized medicine (Jun), 12(6). doi:10.3390/jpm12061009
Waldman L, Richardson B, Hamilton J, Thanos P. (2022) Chronic oral olanzapine treatment but not haloperidol decreases [3H] MK-801 binding in the rat brain Independent of dietary conditions. Neuroscience letters (Jun), 781: 136657.
Marion M, Hamilton J, Richardson B, Roeder N, Figueiredo A, Nubelo A, Hetelekides E, Penman S, Owada Y, Kagawa Y, Thanos PK. (2022) Environmental enrichment sex-dependently rescues memory impairment in FABP5 KO mice not mediated by brain-derived neurotrophic factor. Behavioural brain research (May), 425: 113814.
Hanna C, Hamilton J, Arnavut E, Blum K, Thanos PK. (2022) Brain Mapping the Effects of Chronic Aerobic Exercise in the Rat Brain Using FDG PET. Journal of personalized medicine (May), 12(6). doi:10.3390/jpm12060860
Richer K, Hamilton J, Delis F, Martin C, Fricke D, Yao R, Sajjad M, Blum K, Hadjiargyrou M, Komatsu D, Thanos PK. (2022) Chronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain. Brain research (Apr), 1780: 147799.
Rapp C, Hamilton J, Blum K, Thanos PK. (2022) The long-term interaction of diet and dopamine D2 gene expression on brain microglial activation. Psychiatry research. Neuroimaging (Mar), 320: 111430.
Fearby N, Penman S, Thanos P. (2022) Effects of ?9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review. International journal of environmental research and public health (Mar), 19(6). doi:10.3390/ijerph19063174
Blum K, McLaughlin T, Bowirrat A, Modestino EJ, Baron D, Gomez LL, Ceccanti M, Braverman ER, Thanos PK, Cadet JL, Elman I, Badgaiyan RD, Jalali R, Green R, Simpatico TA, Gupta A, Gold MS. (2022) Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?. Journal of personalized medicine (Feb), 12(2). doi:10.3390/jpm12020321
Richardson B, Swenson S, Hamilton J, Leonard K, Delis F, Gold M, Blum K, Thanos PK. (2022) Chronic neuroleptic treatment combined with a high fat diet elevated [3H] flunitrazepam binding in the cerebellum. Progress in neuro-psychopharmacology & biological psychiatry (Jan), 112: 110407.
Blum K, Gold MS, Cadet JL, Baron D, Bowirrat A, Thanos PK, Brewer R, Badgaiyan RD, Gondré-Lewis MC. (2022) Dopaminylation in Psychostimulant Use Disorder Protects Against Psychostimulant Seeking Behavior by Normalizing Nucleus Accumbens (NAc) Dopamine Expression. Current psychopharmacology (Jan), 11(1): 11-17. doi:10.2174/2211556009666210108112737
Connor C, Hamilton J, Robison L, Hadjiargyrou M, Komatsu D, Thanos P. (2022) Abstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner. Current pharmaceutical design (Jan), 28(4): 331-338.
Blum K, Bowirrat A, Braverman ER, Baron D, Cadet JL, Kazmi S, Elman I, Thanos PK, Badgaiyan RD, Downs WB, Bagchi D, Llanos-Gomez L, Gold MS. (2021) Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions. International journal of environmental research and public health (Nov), 18(21). doi:10.3390/ijerph182111529
Moon C, Marion M, Thanos PK, Steiner H. (2021) Fluoxetine Potentiates Oral Methylphenidate-Induced Gene Regulation in the Rat Striatum. Molecular neurobiology (Oct), 58(10): 4856-4870. doi:10.1007/s12035-021-02466-y
Blum K, Gold MS, Llanos-Gomez L, Jalali R, Thanos PK, Bowirrat A, Downs WB, Bagchi D, Braverman ER, Baron D, Roy AK, Badgaiyan RD. (2021) Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?. International journal of environmental research and public health (Sep), 18(18). doi:10.3390/ijerph18189774
Blum K, Modestino EJ, Baron D, Brewer R, Thanos P, Elman I, Badgaiyan RD, Downs BW, Bagchi D, McLaughlin T, Bowirrat A, Roy AK, Gold MS. (2021) Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic. Current psychopharmacology (Aug), 10(2): 86-97. doi:10.2174/2211556009999210104221215
Maredia M, Hamilton J, Thanos PK. (2021) A high-fat diet, but not haloperidol or olanzapine administration, increases activated microglial expression in the rat brain. Neuroscience letters (Jul), 757: 135976.
Moran M, Blum K, Ponce JV, Lott L, Gondré-Lewis MC, Badgaiyan S, Brewer R, Downs BW, Fynman P, Weingarten A, Cadet JL, Smith DE, Baron D, Thanos PK, Modestino EJ, Badgaiyan RD, Elman I, Gold MS. (2021) High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial. Molecular neurobiology (Jul), 58(7): 3335-3346. doi:10.1007/s12035-021-02312-1
Blum K, Kazmi S, Modestino EJ, Downs BW, Bagchi D, Baron D, McLaughlin T, Green R, Jalali R, Thanos PK, Elman I, Badgaiyan RD, Bowirrat A, Gold MS. (2021) A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration. Journal of personalized medicine (Mar), 11(3). doi:10.3390/jpm11030212
Thanos PK, Gold MS, Blum K, Badgaiyan RD, Avena NM. (2021) Bariatric surgery: Potential post-operative heightened sensitivity to substances or behaviors. Journal of systems and integrative neuroscience (Mar), 8: 1.
Blum K, Bowirrat A, Gondre Lewis MC, Simpatico TA, Ceccanti M, Steinberg B, Modestino EJ, Thanos PK, Baron D, McLaughlin T, Brewer R, Badgaiyan RD, Ponce JV, Lott L, Gold MS. (2021) Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain Development. Current psychopharmacology (Feb), 10. doi:10.2174/2211556010666210215155509
Blum K, Raza A, Schultz T, Jalali R, Green R, Brewer R, Thanos PK, McLaughlin T, Baron D, Bowirrat A, Elman I, Downs BW, Bagchi D, Badgaiyan RD. (2021) Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?. Acta scientific neurology (Feb), 4(2): 17-24.
Jalloh K, Roeder N, Hamilton J, Delis F, Hadjiargyrou M, Komatsu D, Thanos PK. (2021) Chronic oral methylphenidate treatment in adolescent rats promotes dose-dependent effects on NMDA receptor binding. Life sciences (Jan), 264: 118708.
McGregor M, Hamilton J, Hajnal A, Thanos PK. (2020) Roux-en-Y gastric bypass increases GABA-A receptor levels in regions of the rat brain involved in object recognition memory and perceptual acuity. Physiology & behavior (Oct), 224: 113053.
Rahman N, Mihalkovic A, Geary O, Haffey R, Hamilton J, Thanos PK. (2020) Chronic aerobic exercise: Autoradiographic assessment of GABA(a) and mu-opioid receptor binding in adult rats. Pharmacology, biochemistry, and behavior (Sep), 196: 172980.
McGregor M, Richer K, Ananth M, Thanos PK. (2020) The functional networks of a novel environment: Neural activity mapping in awake unrestrained rats using positron emission tomography. Brain and behavior (Aug), 10(8): e01646. doi:10.1002/brb3.1646
Swenson S, Blum K, McLaughlin T, Gold MS, Thanos PK. (2020) The therapeutic potential of exercise for neuropsychiatric diseases: A review. Journal of the neurological sciences (May), 412: 116763.
Kalinowski L, Connor C, Somanesan R, Carias E, Richer K, Smith L, Martin C, Mackintosh M, Popoola D, Hadjiargyrou M, Komatsu DE, Thanos PK. (2020) Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects. Developmental psychobiology (Mar), 62(2): 170-180. doi:10.1002/dev.21902
Fried L, Modestino EJ, Siwicki D, Lott L, Thanos PK, Baron D, Badgaiyan RD, Ponce JV, Giordano J, Downs WB, Gondré-Lewis MC, Bruce S, Braverman ER, Boyett B, Blum K. (2020) Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair. Current pharmaceutical biotechnology (Jan), 21(6): 528-541.
Edwards D, Roy AK, Boyett B, Badgaiyan RD, Thanos PK, Baron D, Hauser M, Badgaiyan S, Brewer R, Siwicki DB, Downs W, Smith DE, Blum K. (2020) Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward Deficiency. Journal of addiction science (Jan), 6(1): 1-4.
Blum K, Gondré-Lewis MC, Modestino EJ, Lott L, Baron D, Siwicki D, McLaughlin T, Howeedy A, Krengel MH, Oscar-Berman M, Thanos PK, Elman I, Hauser M, Fried L, Bowirrat A, Badgaiyan RD. (2019) Understanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides Stigmatization. Molecular neurobiology (Nov), 56(11): 7836-7850. doi:10.1007/s12035-019-1600-8
Blum K, Baron D, Hauser M, Henriksen S, Thanos PK, Black C, Siwicki D, Modestino EJ, Downs BW, Badgaiyan S, Simpatico TA, Boyett B, Badgaiyan RD. (2019) Americas' opioid/psychostimulant epidemic would benefit from general population early identification of genetic addiction risk especially in children of alcoholics (COAs). Journal of systems and integrative neuroscience (Oct), 5(2): 1-3.
Swenson S, Hamilton J, Robison L, Thanos PK. (2019) Chronic aerobic exercise: Lack of effect on brain CB1 receptor levels in adult rats. Life sciences (Aug), 230: 84-88.
Ananth M, Hetelekides EM, Hamilton J, Thanos PK. (2019) Dopamine D4 receptor gene expression plays important role in extinction and reinstatement of cocaine-seeking behavior in mice. Behavioural brain research (Jun), 365: 1-6.
McGregor M, Hamilton J, Hajnal A, Thanos PK. (2019) Roux-en-Y gastric bypass in rat reduces mu-opioid receptor levels in brain regions associated with stress and energy regulation. PloS one (Jan), 14(6): e0218680. doi:10.1371/journal.pone.0218680
Carias E, Fricke D, Vijayashanthar A, Smith L, Somanesan R, Martin C, Kalinowski L, Popoola D, Hadjiargyrou M, Komatsu DE, Thanos PK, Thanos P. (2019) Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects. Behav Brain Res (Jan), 356: 189-196.
Carias E, Hamilton J, Robison LS, Delis F, Eiden R, Quattrin T, Hadjiargyrou M, Komatsu D, Thanos PK, Thanos P. (2018) Chronic oral methylphenidate treatment increases microglial activation in rats. J Neural Transm (Vienna) (Dec), 125(12): 1867-1875.
Robison LS, Alessi L, Thanos PK, Thanos P. (2018) Chronic forced exercise inhibits stress-induced reinstatement of cocaine conditioned place preference. Behav Brain Res (Nov), 353: 176-184.
Blum K, Jacobs W, Modestino EJ, DiNubile N, Baron D, McLaughlin T, Siwicki D, Elman I, Moran M, Braverman ER, Thanos PK, Badgaiyan RD, Thanos P. (2018) Insurance Companies Fighting the Peer Review Empire without any Validity: the Case for Addiction and Pain Modalities in the face of an American Drug Epidemic. SEJ Surg Pain (Oct), 1(1): 1-11.
Martin C, Fricke D, Vijayashanthar A, Lowinger C, Koutsomitis D, Popoola D, Hadjiargyrou M, Komatsu DE, Thanos PK, Thanos P. (2018) Recovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period. Pharmacol Biochem Behav (Sep), 172: 22-32.
Hamilton J, Koumas C, Clavin BH, Marion M, Figueiredo A, Gonzalez S, O'Rourke JR, Deutsch D, Kaczocha M, Haj-Dahmane S, Thanos PK. (2018) Fatty acid-binding proteins 5 and 7 gene deletion increases sucrose consumption and diminishes forced swim immobility time. Behavioural pharmacology (Sep), 29(6): 503-508. doi:10.1097/FBP.0000000000000402
Blum K, Modestino EJ, Badgaiyan RD, Baron D, Thanos PK, Elman I, Siwicki D, Febo M, Gold MS, Thanos P. (2018) Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse. EC Psychol Psychiatr (Aug), 7(8): 564-579.
Robison LS, Swenson S, Hamilton J, Thanos PK, Thanos P. (2018) Exercise Reduces Dopamine D1R and Increases D2R in Rats: Implications for Addiction. Med Sci Sports Exerc (Aug), 50(8): 1596-1602.
Hamilton J, Swenson S, Hajnal A, Thanos PK, Thanos P. (2018) Roux-en-Y gastric bypass surgery normalizes dopamine D1, D2, and DAT levels. Synapse (Jul).
Michaelides M, Miller ML, Egervari G, Primeaux SD, Gomez JL, Ellis RJ, Landry JA, Szutorisz H, Hoffman AF, Lupica CR, Loos RJF, Thanos PK, Bray GA, Neumaier JF, Zachariou V, Wang GJ, Volkow ND, Hurd YL, Thanos P. (2018) Striatal Rgs4 regulates feeding and susceptibility to diet-induced obesity. Mol Psychiatry (Jun).
Hamilton J, Marion M, Figueiredo A, Clavin BH, Deutsch D, Kaczocha M, Haj-Dahmane S, Thanos PK. (2018) Fatty acid binding protein deletion prevents stress-induced preference for cocaine and dampens stress-induced corticosterone levels. Synapse (New York, N.Y.) (Jun), 72(6): e22031. doi:10.1002/syn.22031
Haj-Dahmane S, Shen RY, Elmes MW, Studholme K, Kanjiya MP, Bogdan D, Thanos PK, Miyauchi JT, Tsirka SE, Deutsch DG, Kaczocha M. (2018) Fatty-acid-binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses. Proceedings of the National Academy of Sciences of the United States of America (Mar), 115(13): 3482-3487. doi:10.1073/pnas.1721339115
Thanos PK, Zhuo J, Robison L, Kim R, Ananth M, Choai I, Grunseich A, Grissom NM, George R, Delis F, Reyes TM, Thanos P. (2018) Suboptimal maternal diets alter mu opioid receptor and dopamine type 1 receptor binding but exert no effect on dopamine transporters in the offspring brain. Int J Dev Neurosci (Feb), 64: 21-28.
Blum K, Thanos PK, Wang GJ, Febo M, Demetrovics Z, Modestino EJ, Braverman ER, Baron D, Badgaiyan RD, Gold MS, Thanos P. (2018) The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis. Curr Pharm Des (Feb), 23(39): 6050-6061.
Blum K, Modestino EJ, Gondre-Lewis M, Chapman EJ, Neary J, Siwicki D, Baron D, Hauser M, Smith DE, Roy AK, Thanos PK, Steinberg B, McLaughlin T, Fried L, Barh D, Dunston GA, Badgaiyan RD, Thanos P. (2018) The Benefits of Genetic Addiction Risk Score (GARSâ„¢) Testing in Substance Use Disorder (SUD). Int J Genom Data Min (Jan), 2018(1).
Blum K, Chen ALC, Thanos PK, Febo M, Demetrovics Z, Dushaj K, Kovoor A, Baron D, Smith DE, Roy AK, Fried L, Chen TJH, Chapman E, Modestino EJ, Steinberg B, Badgaiyan RD, Thanos P. (2018) Genetic addiction risk score (GARS) â„¢, a predictor of vulnerability to opioid dependence. Front Biosci (Elite Ed) (Jan), 10: 175-196.
Uddin SMZ, Robison LS, Fricke D, Chernoff E, Hadjiargyrou M, Thanos PK, Komatsu DE, Thanos P. (2018) Methylphenidate regulation of osteoclasts in a dose- and sex-dependent manner adversely affects skeletal mechanical integrity. Sci Rep (Jan), 8(1): 1515-1515.
Blum K, Gondré-Lewis MC, Baron D, Thanos PK, Braverman ER, Neary J, Elman I, Badgaiyan RD. (2018) Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors. Frontiers in psychiatry (Jan), 9: 548. doi:10.3389/fpsyt.2018.00548
McLaughlin T, Blum K, Steinberg B, Siwicki D, Campione J, Badgaiyan RD, Braverman ER, Modestino EJ, GondrÃ©-Lewis MC, Baron D, Mash DC, Giordano J, Thanos PK, Thanos P. (2017) Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: "Born Bad". J Reward Defic Syndr Addict Sci (Dec), 3(2): 28-31.
Delis F, Rosko L, Shroff A, Leonard KE, Thanos PK, Thanos P. (2017) Oral haloperidol or olanzapine intake produces distinct and region-specific increase in cannabinoid receptor levels that is prevented by high fat diet. Prog Neuropsychopharmacol Biol Psychiatry (Oct), 79(Pt B): 268-280.
Robison LS, Ananth M, Hadjiargyrou M, Komatsu DE, Thanos PK, Thanos P. (2017) Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats. J Neural Transm (Vienna) (May), 124(5): 655-667.
Febo M, Blum K, Badgaiyan RD, Perez PD, Colon-Perez LM, Thanos PK, Ferris CF, Kulkarni P, Giordano J, Baron D, Gold MS, Thanos P. (2017) Enhanced functional connectivity and volume between cognitive and reward centers of naÃ¯ve rodent brain produced by pro-dopaminergic agent KB220Z. PLoS One (Apr), 12(4): 0174774-0174774.
Robison LS, Michaelos M, Gandhi J, Fricke D, Miao E, Lam CY, Mauceri A, Vitale M, Lee J, Paeng S, Komatsu DE, Hadjiargyrou M, Thanos PK, Thanos P. (2017) Sex Differences in the Physiological and Behavioral Effects of Chronic Oral Methylphenidate Treatment in Rats. Front Behav Neurosci (Mar), 11: 53-53.
Blum K, Gold M, Demetrovics Z, Archer T, Thanos PK, Baron D, Badgaiyan RD, Thanos P. (2017) Substance use disorder a bio-directional subset of reward deficiency syndrome. Front Biosci (Landmark Ed) (Jan), 22: 1534-1548.
Thanos PK, Restif C, O'Rourke JR, Lam CY, Metaxas D, Thanos P. (2017) Mouse Social Interaction Test (MoST): a quantitative computer automated analysis of behavior. J Neural Transm (Vienna) (Jan), 124(1): 3-11.
Febo M, Blum K, Badgaiyan RD, Baron D, Thanos PK, Colon-Perez LM, Demortrovics Z, Gold MS, Thanos P. (2017) Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. Front Biosci (Landmark Ed) (Jan), 22: 669-691.
Thanos PK, Kim R, Delis F, Rocco MJ, Cho J, Volkow ND, Thanos P. (2017) Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain. Behav Brain Res (Jan), 320: 282-290.
Figueiredo A, Hamilton J, Marion M, Blum K, Kaczocha M, Haj-Dahmane S, Deutsch D, Thanos PK. (2017) Pharmacological Inhibition of Brain Fatty Acid Binding Protein Reduces Ethanol Consumption in Mice. Journal of reward deficiency syndrome and addiction science (Jan), 3(2): 21-27.
Blum K, Badgaiyan RD, Braverman ER, Dushaj K, Li M, Thanos PK, Demetrovics Z, Febo M, Thanos P. (2016) Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term. J Reward Defic Syndr Addict Sci (Jun), 2(1): 14-21.
Thanos PK, Kim R, Delis F, Ananth M, Chachati G, Rocco MJ, Masad I, Muniz JA, Grant SC, Gold MS, Cadet JL, Volkow ND, Thanos P. (2016) Chronic Methamphetamine Effects on Brain Structure and Function in Rats. PLoS One (Jun), 11(6): 0155457-0155457.
Thanos PK, Hamilton J, O'Rourke JR, Napoli A, Febo M, Volkow ND, Blum K, Gold M, Thanos P. (2016) Dopamine D2 gene expression interacts with environmental enrichment to impact lifespan and behavior. Oncotarget (Apr), 7(15): 19111-19123.
Roux A, Jackson SN, Muller L, Barbacci D, O'Rourke J, Thanos PK, Volkow ND, Balaban C, Schultz JA, Woods AS, Thanos P. (2016) Ethanol Induced Brain Lipid Changes in Mice Assessed by Mass Spectrometry. ACS Chem Neurosci (Jan), 7(8): 1148-1156.
Thanos PK, Malave L, Delis F, Mangine P, Kane K, Grunseich A, Vitale M, Greengard P, Volkow ND, Thanos P. (2016) Knockout of p11 attenuates the acquisition and reinstatement of cocaine conditioned place preference in male but not in female mice. Synapse (Jan), 70(7): 293-301.
Thanos PK, Clavin BH, Hamilton J, O'Rourke JR, Maher T, Koumas C, Miao E, Lankop J, Elhage A, Haj-Dahmane S, Deutsch D, Kaczocha M. (2016) Examination of the Addictive and Behavioral Properties of Fatty Acid-Binding Protein Inhibitor SBFI26. Frontiers in psychiatry (Jan), 7: 54. doi:10.3389/fpsyt.2016.00054
Blum K, Febo M, Thanos PK, Baron D, Fratantonio J, Gold M, Thanos P. (2015) Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?. Mol Neurobiol (Dec), 52(3): 1862-1869.
Kaczocha M, Glaser ST, Maher T, Clavin B, Hamilton J, O'Rourke J, Rebecchi M, Puopolo M, Owada Y, Thanos PK, Thanos P. (2015) Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms. Mol Pain (Aug), 11: 52-52.
Blum K, Thanos PK, Badgaiyan RD, Febo M, Oscar-Berman M, Fratantonio J, Demotrovics Z, Gold MS, Thanos P. (2015) Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land?. Expert Opin Biol Ther (Jul), 15(7): 973-985.
Thanos PK, Roushdy K, Sarwar Z, Rice O, Ashby CR, Grandy DK, Thanos P. (2015) The effect of dopamine D4 receptor density on novelty seeking, activity, social interaction, and alcohol binge drinking in adult mice. Synapse (Jul), 69(7): 356-364.
Thanos PK, Michaelides M, Subrize M, Miller ML, Bellezza R, Cooney RN, Leggio L, Wang GJ, Rogers AM, Volkow ND, Hajnal A, Thanos P. (2015) Roux-en-Y Gastric Bypass Alters Brain Activity in Regions that Underlie Reward and Taste Perception. PLoS One (Jun), 10(6): 0125570-0125570.
Delis F, Rombola C, Bellezza R, Rosko L, Grandy DK, Volkow ND, Thanos PK, Thanos P. (2015) Regulation of ethanol intake under chronic mild stress: roles of dopamine receptors and transporters. Front Behav Neurosci (May), 9: 118-118.
Thanos PK, Robison LS, Steier J, Hwang YF, Cooper T, Swanson JM, Komatsu DE, Hadjiargyrou M, Volkow ND, Thanos P. (2015) A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior. Pharmacol Biochem Behav (Apr), 131: 143-153.
Volkow ND, Wang GJ, Logan J, Alexoff D, Fowler JS, Thanos PK, Wong C, Casado V, Ferre S, Tomasi D, Thanos P. (2015) Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain. Transl Psychiatry (Apr), 5: 549-549.
Roux A, Muller L, Jackson SN, Baldwin K, Womack V, Pagiazitis JG, O'Rourke JR, Thanos PK, Balaban C, Schultz JA, Volkow ND, Woods AS, Thanos P. (2015) Chronic ethanol consumption profoundly alters regional brain ceramide and sphingomyelin content in rodents. ACS Chem Neurosci (Feb), 6(2): 247-259.
Blum K, Thanos PK, Oscar-Berman M, Febo M, Baron D, Badgaiyan RD, Gardner E, Demetrovics Z, Fahlke C, Haberstick BC, Dushaj K, Gold MS, Thanos P. (2015) Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction. J Reward Defic Syndr (Jan), 1(3): 95-104.
Blum K, Thanos PK, Gold MS, Thanos P. (2014) Dopamine and glucose, obesity, and reward deficiency syndrome. Front Psychol (Sep), 5: 919-919.
Cassataro D, Bergfeldt D, Malekian C, Van Snellenberg JX, Thanos PK, Fishell G, Sjulson L. (2014) Reverse pharmacogenetic modulation of the nucleus accumbens reduces ethanol consumption in a limited access paradigm. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (Jan), 39(2): 283-90. doi:10.1038/npp.2013.184
Michaelides M, Anderson SA, Ananth M, Smirnov D, Thanos PK, Neumaier JF, Wang GJ, Volkow ND, Hurd YL. (2013) Whole-brain circuit dissection in free-moving animals reveals cell-specific mesocorticolimbic networks. The Journal of clinical investigation (Dec), 123(12): 5342-50. doi:10.1172/JCI72117
Anderson SA, Michaelides M, Zarnegar P, Ren Y, Fagergren P, Thanos PK, Wang GJ, Bannon M, Neumaier JF, Keller E, Volkow ND, Hurd YL. (2013) Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression. The Journal of clinical investigation (Dec), 123(12): 5334-41. doi:10.1172/JCI70395
Saint-Preux F, Bores LR, Tulloch I, Ladenheim B, Kim R, Thanos PK, Volkow ND, Cadet JL. (2013) Chronic co-administration of nicotine and methamphetamine causes differential expression of immediate early genes in the dorsal striatum and nucleus accumbens of rats. Neuroscience (Jul), 243: 89-96. doi:10.1016/j.neuroscience.2013.03.052
Michaelides M, Miller ML, Subrize M, Kim R, Robison L, Hurd YL, Wang GJ, Volkow ND, Thanos PK. (2013) Limbic activation to novel versus familiar food cues predicts food preference and alcohol intake. Brain research (May), 1512: 37-44. doi:10.1016/j.brainres.2013.03.006
Thanos PK, Robison L, Nestler EJ, Kim R, Michaelides M, Lobo MK, Volkow ND. (2013) Mapping brain metabolic connectivity in awake rats with µPET and optogenetic stimulation. The Journal of neuroscience : the official journal of the Society for Neuroscience (Apr), 33(15): 6343-9. doi:10.1523/JNEUROSCI.4997-12.2013
Thanos PK, Robison LS, Robinson JK, Michaelides M, Wang GJ, Volkow ND, Thanos P. (2013) Obese rats with deficient leptin signaling exhibit heightened sensitivity to olfactory food cues. Synapse (Apr), 67(4): 171-178.
Thanos P, Delis F, Rosko L, Volkow ND. (2013) Passive Response to Stress in Adolescent Female and Adult Male Mice after Intermittent Nicotine Exposure in Adolescence. J Addict Res Ther (Apr), Suppl: 007-007.
Thanos PK, Stamos J, Robison LS, Heyman G, Tucci A, Wang GJ, Robinson JK, Anderson BJ, Volkow ND, Thanos P. (2013) Daily treadmill exercise attenuates cocaine cue-induced reinstatement and cocaine induced locomotor response but increases cocaine-primed reinstatement. Behav Brain Res (Feb), 239: 8-14.
Delis F, Thanos PK, Rombola C, Rosko L, Grandy D, Wang GJ, Volkow ND, Thanos P. (2013) Chronic mild stress increases alcohol intake in mice with low dopamine D2 receptor levels. Behav Neurosci (Feb), 127(1): 95-105.
Grady DL, Thanos PK, Corrada MM, Barnett JC, Ciobanu V, Shustarovich D, Napoli A, Moyzis AG, Grandy D, Rubinstein M, Wang GJ, Kawas CH, Chen C, Dong Q, Wang E, Volkow ND, Moyzis RK. (2013) DRD4 genotype predicts longevity in mouse and human. The Journal of neuroscience : the official journal of the Society for Neuroscience (Jan), 33(1): 286-91. doi:10.1523/JNEUROSCI.3515-12.2013
Polston JE, Pritchett CE, Tomasko JM, Rogers AM, Leggio L, Thanos PK, Volkow ND, Hajnal A. (2013) Roux-en-Y gastric bypass increases intravenous ethanol self-administration in dietary obese rats. PloS one (Jan), 8(12): e83741. doi:10.1371/journal.pone.0083741
Alzghoul L, Bortolato M, Delis F, Thanos PK, Darling RD, Godar SC, Zhang J, Grant S, Wang GJ, Simpson KL, Chen K, Volkow ND, Lin RC, Shih JC, Thanos P. (2012) Altered cerebellar organization and function in monoamine oxidase A hypomorphic mice. Neuropharmacology (Dec), 63(7): 1208-1217.
Thanos PK, Subrize M, Delis F, Cooney RN, Culnan D, Sun M, Wang GJ, Volkow ND, Hajnal A, Thanos P. (2012) Gastric bypass increases ethanol and water consumption in diet-induced obese rats. Obes Surg (Dec), 22(12): 1884-1892.
Hajnal A, Zharikov A, Polston JE, Fields MR, Tomasko J, Rogers AM, Volkow ND, Thanos PK, Thanos P. (2012) Alcohol reward is increased after Roux-en-Y gastric bypass in dietary obese rats with differential effects following ghrelin antagonism. PLoS One (Nov), 7(11): 49121-49121.
Wang GJ, Smith L, Volkow ND, Telang F, Logan J, Tomasi D, Wong CT, Hoffman W, Jayne M, Alia-Klein N, Thanos P, Fowler JS. (2012) Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry (Sep), 17(9): 918-925.
Michaelides M, Thanos PK, Volkow ND, Wang GJ, Thanos P. (2012) Dopamine-related frontostriatal abnormalities in obesity and binge-eating disorder: emerging evidence for developmental psychopathology. Int Rev Psychiatry (Jun), 24(3): 211-218.
Komatsu DE, Thanos PK, Mary MN, Janda HA, John CM, Robison L, Ananth M, Swanson JM, Volkow ND, Hadjiargyrou M, Thanos P. (2012) Chronic exposure to methylphenidate impairs appendicular bone quality in young rats. Bone (Jun), 50(6): 1214-1222.
Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, Logan J, Benveniste H, Kim R, Thanos PK, FerrÃ© S, Thanos P. (2012) Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain. J Neurosci (May), 32(19): 6711-6717.
Delis F, Benveniste H, Xenos M, Grandy D, Wang GJ, Volkow ND, Thanos PK. (2012) Loss of dopamine D2 receptors induces atrophy in the temporal and parietal cortices and the caudal thalamus of ethanol-consuming mice. Alcoholism, clinical and experimental research (May), 36(5): 815-25.
Michaelides M, Thanos PK, Volkow ND, Wang GJ. (2012) Translational neuroimaging in drug addiction and obesity. ILAR journal (Jan), 53(1): 59-68.
Michaelides M, Thanos PK, Kim R, Cho J, Ananth M, Wang GJ, Volkow ND. (2012) PET imaging predicts future body weight and cocaine preference. NeuroImage (Jan), 59(2): 1508-13. doi:10.1016/j.neuroimage.2011.08.028
Thanos PK, Subrize M, Lui W, Puca Z, Ananth M, Michaelides M, Wang GJ, Volkow ND. (2011) D-cycloserine facilitates extinction of cocaine self-administration in C57 mice. Synapse (New York, N.Y.) (Oct), 65(10): 1099-105. doi:10.1002/syn.20944
Thanos PK, Bermeo C, Wang GJ, Volkow ND. (2011) D-cycloserine facilitates extinction of cocaine self-administration in rats. Synapse (New York, N.Y.) (Sep), 65(9): 938-44. doi:10.1002/syn.20922
Vakalopoulos I, Thanos P, Gkotsos G, Radopoulos D. (2011) Are vascular disorders a common cause of erectile dysfunction in non hypogonadal, non neuropsychiatric patients?. Hippokratia (Jul), 15(3): 244-246.
Thanos PK, Cho J, Kim R, Michaelides M, Primeaux S, Bray G, Wang GJ, Volkow ND. (2011) Bromocriptine increased operant responding for high fat food but decreased chow intake in both obesity-prone and resistant rats. Behavioural brain research (Feb), 217(1): 165-70. doi:10.1016/j.bbr.2010.10.027
Thanos PK, Gopez V, Delis F, Michaelides M, Grandy DK, Wang GJ, Kunos G, Volkow ND. (2011) Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption. Alcoholism, clinical and experimental research (Jan), 35(1): 19-27. doi:10.1111/j.1530-0277.2010.01318.x
Zhang S, Huang J, Uzunbas M, Shen T, Delis F, Huang X, Volkow N, Thanos P, Metaxas DN. (2011) 3D segmentation of rodent brain structures using hierarchical shape priors and deformable models. Med Image Comput Comput Assist Interv (Jan), 14(Pt 3): 611-618.
Thanos PK, Tucci A, Stamos J, Robison L, Wang GJ, Anderson BJ, Volkow ND, Thanos P. (2010) Chronic forced exercise during adolescence decreases cocaine conditioned place preference in Lewis rats. Behav Brain Res (Dec), 215(1): 77-82.
Thanos PK, Kim R, Cho J, Michaelides M, Anderson BJ, Primeaux SD, Bray GA, Wang GJ, Robinson JK, Volkow ND, Thanos P. (2010) Obesity-resistant S5B rats showed greater cocaine conditioned place preference than the obesity-prone OM rats. Physiol Behav (Dec), 101(5): 713-718.
Volkow ND, Fowler JS, Wang GJ, Shumay E, Telang F, Thanos PK, Alexoff D. (2010) Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications. PloS one (Dec), 5(12): e15269. doi:10.1371/journal.pone.0015269
Michaelides M, Pascau J, Gispert JD, Delis F, Grandy DK, Wang GJ, Desco M, Rubinstein M, Volkow ND, Thanos PK, Thanos P. (2010) Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate. Eur J Neurosci (Aug), 32(4): 668-676.
Pfaffly J, Michaelides M, Wang GJ, Pessin JE, Volkow ND, Thanos PK, Thanos P. (2010) Leptin increases striatal dopamine D2 receptor binding in leptin-deficient obese (ob/ob) mice. Synapse (Jul), 64(7): 503-510.
Thanos PK, Bermeo C, Rubinstein M, Suchland KL, Wang GJ, Grandy DK, Volkow ND, Thanos P. (2010) Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors. J Psychopharmacol (Jun), 24(6): 897-904.
Thanos PK, Habibi R, Michaelides M, Patel UB, Suchland K, Anderson BJ, Robinson JK, Wang GJ, Grandy DK, Volkow ND, Thanos P. (2010) Dopamine D4 receptor (D4R) deletion in mice does not affect operant responding for food or cocaine. Behav Brain Res (Mar), 207(2): 508-511.
Thanos PK, Ivanov I, Robinson JK, Michaelides M, Wang GJ, Swanson JM, Newcorn JH, Volkow ND, Thanos P. (2010) Dissociation between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats in baseline performance and methylphenidate response on measures of attention, impulsivity and hyperactivity in a Visual Stimulus Position Discrimination Task. Pharmacol Biochem Behav (Jan), 94(3): 374-379.
Thanos PK, Bermeo C, Wang GJ, Volkow ND, Thanos P. (2009) D-cycloserine accelerates the extinction of cocaine-induced conditioned place preference in C57bL/c mice. Behav Brain Res (May), 199(2): 345-349.
Wang GJ, Volkow ND, Thanos PK, Fowler JS, Thanos P. (2009) Imaging of brain dopamine pathways: implications for understanding obesity. J Addict Med (Mar), 3(1): 8-18.
Radopoulos D, Vakalopoulos I, Thanos P. (2009) Preputial graft in penile curvature correction: preliminary results. Int J Impot Res (Jan), 21(1): 82-87.
Wang GJ, Volkow ND, Telang F, Jayne M, Ma Y, Pradhan K, Zhu W, Wong CT, Thanos PK, Geliebter A, Biegon A, Fowler JS, Thanos P. (2009) Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation. Proc Natl Acad Sci U S A (Jan), 106(4): 1249-1254.
Davis LM, Michaelides M, Cheskin LJ, Moran TH, Aja S, Watkins PA, Pei Z, Contoreggi C, McCullough K, Hope B, Wang GJ, Volkow ND, Thanos PK. (2009) Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity. Neuroendocrinology (Jan), 89(2): 152-62. doi:10.1159/000170586
Volkow ND, Wang GJ, Telang F, Fowler JS, Goldstein RZ, Alia-Klein N, Logan J, Wong C, Thanos PK, Ma Y, Pradhan K. (2009) Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity (Silver Spring, Md.) (Jan), 17(1): 60-5. doi:10.1038/oby.2008.469
Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J, Alexoff D, Ding YS, Wong C, Ma Y, Pradhan K. (2008) Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. NeuroImage (Oct), 42(4): 1537-43. doi:10.1016/j.neuroimage.2008.06.002
Thanos PK, Ramalhete RC, Michaelides M, Piyis YK, Wang GJ, Volkow ND. (2008) Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions. Synapse (New York, N.Y.) (Sep), 62(9): 637-42. doi:10.1002/syn.20531
Vinod KY, Yalamanchili R, Thanos PK, Vadasz C, Cooper TB, Volkow ND, Hungund BL. (2008) Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice. Synapse (New York, N.Y.) (Aug), 62(8): 574-81. doi:10.1002/syn.20533
Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Wong C, Ma J, Pradhan K, Tomasi D, Thanos PK, Ferré S, Jayne M. (2008) Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain. The Journal of neuroscience : the official journal of the Society for Neuroscience (Aug), 28(34): 8454-61. doi:10.1523/JNEUROSCI.1443-08.2008
Thanos PK, Michaelides M, Umegaki H, Volkow ND. (2008) D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse (New York, N.Y.) (Jul), 62(7): 481-6. doi:10.1002/syn.20523
Thanos PK, Michaelides M, Gispert JD, Pascau J, Soto-Montenegro ML, Desco M, Wang R, Wang GJ, Volkow ND. (2008) Differences in response to food stimuli in a rat model of obesity: in-vivo assessment of brain glucose metabolism. International journal of obesity (2005) (Jul), 32(7): 1171-9. doi:10.1038/ijo.2008.50
Thanos PK, Michaelides M, Ho CW, Wang GJ, Newman AH, Heidbreder CA, Ashby CR, Gardner EL, Volkow ND, Thanos P. (2008) The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity. Pharmacol Biochem Behav (Jun), 89(4): 499-507.
Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND, Thanos P. (2008) The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice. Synapse (May), 62(5): 319-324.
Thanos PK, Cavigelli SA, Michaelides M, Olvet DM, Patel U, Diep MN, Volkow ND, Thanos P. (2008) A non-invasive method for detecting the metabolic stress response in rodents: characterization and disruption of the circadian corticosterone rhythm. Physiol Res (Apr), 58(2): 219-228.
Wang GJ, Tomasi D, Backus W, Wang R, Telang F, Geliebter A, Korner J, Bauman A, Fowler JS, Thanos PK, Volkow ND, Thanos P. (2008) Gastric distention activates satiety circuitry in the human brain. Neuroimage (Feb), 39(4): 1824-1831.
Thanos PK, Michaelides M, Piyis YK, Wang GJ, Volkow ND, Thanos P. (2008) Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo muPET imaging ([11C] raclopride) and in-vitro ([3H] spiperone) autoradiography. Synapse (Jan), 62(1): 50-61.
Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND, Thanos P. (2007) Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharmacol Biochem Behav (Oct), 87(4): 426-433.
RodrÃguez-GÃ³mez JA, Lu JQ, Velasco I, Rivera S, Zoghbi SS, Liow JS, Musachio JL, Chin FT, Toyama H, Seidel J, Green MV, Thanos PK, Ichise M, Pike VW, Innis RB, McKay RD, Thanos P. (2007) Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells (Apr), 25(4): 918-928.
Wang GJ, Yang J, Volkow ND, Telang F, Ma Y, Zhu W, Wong CT, Tomasi D, Thanos PK, Fowler JS. (2006) Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry. Proceedings of the National Academy of Sciences of the United States of America (Oct), 103(42): 15641-5. doi:10.1073/pnas.0601977103
Volkow ND, Wang GJ, Begleiter H, Porjesz B, Fowler JS, Telang F, Wong C, Ma Y, Logan J, Goldstein R, Alexoff D, Thanos PK. (2006) High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Archives of general psychiatry (Sep), 63(9): 999-1008.
Rice O, Saintvictor S, Michaelides M, Thanos P, Gatley SJ. (2006) MicroPET investigation of chronic long-term neurotoxicity from heavy ion irradiation. AAPS J (Aug), 8(3): 508-514.
Volkow ND, Wang GJ, Franceschi D, Fowler JS, Thanos PP, Maynard L, Gatley SJ, Wong C, Veech RL, Kunos G, Kai Li T. (2006) Low doses of alcohol substantially decrease glucose metabolism in the human brain. NeuroImage (Jan), 29(1): 295-301.
Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND. (2005) Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behavioural brain research (Nov), 164(2): 206-13.
Heidbreder CA, Gardner EL, Xi ZX, Thanos PK, Mugnaini M, Hagan JJ, Ashby CR. (2005) The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain research. Brain research reviews (Jul), 49(1): 77-105. doi:10.1016/j.brainresrev.2004.12.033
Thanos PK, Rivera SN, Weaver K, Grandy DK, Rubinstein M, Umegaki H, Wang GJ, Hitzemann R, Volkow ND. (2005) Dopamine D2R DNA transfer in dopamine D2 receptor-deficient mice: effects on ethanol drinking. Life sciences (May), 77(2): 130-9.
Thanos PK, Katana JM, Ashby CR, Michaelides M, Gardner EL, Heidbreder CA, Volkow ND. (2005) The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats. Pharmacology, biochemistry, and behavior (May), 81(1): 190-7.
Ding YS, Gatley SJ, Thanos PK, Shea C, Garza V, Xu Y, Carter P, King P, Warner D, Taintor NB, Park DJ, Pyatt B, Fowler JS, Volkow ND. (2004) Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration. Synapse (New York, N.Y.) (Sep), 53(3): 168-75.
Thanos PK, Taintor NB, Rivera SN, Umegaki H, Ikari H, Roth G, Ingram DK, Hitzemann R, Fowler JS, Gatley SJ, Wang GJ, Volkow ND. (2004) DRD2 gene transfer into the nucleus accumbens core of the alcohol preferring and nonpreferring rats attenuates alcohol drinking. Alcoholism, clinical and experimental research (May), 28(5): 720-8.
Heidbreder CA, Andreoli M, Marcon C, Thanos PK, Ashby CR, Gardner EL. (2004) Role of dopamine D3 receptors in the addictive properties of ethanol. Drugs of today (Barcelona, Spain : 1998) (Apr), 40(4): 355-65.
Wang GJ, Volkow ND, Thanos PK, Fowler JS. (2004) Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. Journal of addictive diseases (Jan), 23(3): 39-53.
Alexoff DL, Vaska P, Marsteller D, Gerasimov T, Li J, Logan J, Fowler JS, Taintor NB, Thanos PK, Volkow ND, Thanos P. (2003) Reproducibility of 11C-raclopride binding in the rat brain measured with the microPET R4: effects of scatter correction and tracer specific activity. J Nucl Med (May), 44(5): 815-822.
Hitzemann R, Hitzemann B, Rivera S, Gatley J, Thanos P, Shou LL, Williams RW. (2003) Dopamine D2 receptor binding, Drd2 expression and the number of dopamine neurons in the BXD recombinant inbred series: genetic relationships to alcohol and other drug associated phenotypes. Alcohol Clin Exp Res (Jan), 27(1): 1-11.
Volkow ND, Wang GJ, Fowler JS, Thanos PP, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas N, Thanos P. (2002) Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse (Nov), 46(2): 79-82.
Thanos PK, Taintor NB, Alexoff D, Vaska P, Logan J, Grandy DK, Fang Y, Lee JH, Fowler JS, Volkow ND, Rubinstein M. (2002) In vivo comparative imaging of dopamine D2 knockout and wild-type mice with (11)C-raclopride and microPET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (Nov), 43(11): 1570-7.
Thanos PK, Volkow ND, Freimuth P, Umegaki H, Ikari H, Roth G, Ingram DK, Hitzemann R. (2001) Overexpression of dopamine D2 receptors reduces alcohol self-administration. Journal of neurochemistry (Sep), 78(5): 1094-103.
Thanos PK, Tiangco DA, Terzis JK. (2001) Enhanced reinnervation of the paralyzed orbicularis oculi muscle after insulin-like growth factor-I (IGF-I) delivery to a nerve graft. Journal of reconstructive microsurgery (Jul), 17(5): 357-62.
Wang GJ, Volkow ND, Franceschi D, Fowler JS, Thanos PK, Scherbaum N, Pappas N, Wong CT, Hitzemann RJ, Felder CA. (2000) Regional brain metabolism during alcohol intoxication. Alcoholism, clinical and experimental research (Jun), 24(6): 822-9.
Volkow ND, Wang GJ, Fowler JS, Franceschi D, Thanos PK, Wong C, Gatley SJ, Ding YS, Molina P, Schlyer D, Alexoff D, Hitzemann R, Pappas N. (2000) Cocaine abusers show a blunted response to alcohol intoxication in limbic brain regions. Life sciences (Feb), 66(12): PL161-7.
Thanos PK, Okajima S, Tiangco DA, Terzis JK, Thanos P. (1999) Insulin-like growth factor-I promotes nerve regeneration through a nerve graft in an experimental model of facial paralysis. Restor Neurol Neurosci (Jan), 15(1): 57-71.
Thanos PK, Okajima S, Terzis JK. (1998) Ultrastructure and cellular biology of nerve regeneration. Journal of reconstructive microsurgery (Aug), 14(6): 423-36.
Thanos PK, Slotnick BM. (1997) Short-term odor memory: effects of posterior transection of the lateral olfactory tract in the rat. Physiology & behavior (Jun), 61(6): 903-6.
Terzis JK, Sun DD, Thanos PK. (1997) Historical and basic science review: past, present, and future of nerve repair. Journal of reconstructive microsurgery (Apr), 13(3): 215-25.
Thanos PK, Terzis JK. (1996) A histomorphometric analysis of the cross-facial nerve graft in the treatment of facial paralysis. Journal of reconstructive microsurgery (Aug), 12(6): 375-82.
Thanos PK, Terzis JK. (1995) Motor endplate analysis of the denervated and reinnervated orbicularis oculi muscle in the rat. Journal of reconstructive microsurgery (Nov), 11(6): 423-8.
Thanos PK, Jhamandas K, Beninger RJ. (1992) N-methyl-D-aspartate unilaterally injected into the dorsal striatum of rats produces contralateral circling: antagonism by 2-amino-7-phosphonoheptanoic acid and cis-flupenthixol. Brain research (Aug), 589(1): 55-61.
Pascau J, Gispert JD, Michaelides M, Thanos PK, Volkow ND, Vaquero JJ, Soto-Montenegro ML, Desco M. (1900) Automated method for small-animal PET image registration with intrinsic validation. Molecular imaging and biology (Jan), 11(2): 107-13. doi:10.1007/s11307-008-0166-z
Perreault B, Hammond N, Thanos PK. (1900) Effects of Exercise on Testosterone and Implications of Drug Abuse: A Review. Clinical neuropharmacology (Jan), 46(3): 112-122.

See all (261 more)

Professional Memberships:

International Society of Reward Deficiency; member (2015–2019)
Research Society on Alcoholism; Member (1999–present)
Society for Neuroscience; Member (1995–present)

Presentations:

"Development of UPLC-MS/MS Method to Quantify Baseline Levels of Endocannabinoids in Mouse Brain" Cannabis Clinical Outcomes Research Conference (CCORC) (2024)
"Pharmacogenomic evolutionary mystery surrounding gender differential in the Pre-addiction liability of males compared to females: Y chromosome promotes risk and X chromosome promotes nurture" XXVII World Congress of Neurology
"Effects of Tetrahydrocannabinol on Prenatal Skeletal Development." 2024. Orthopaedic Research Society Annual Meeting. February 2-6, Long Beach, CA,
"Exercise Effects on Behavior, Neurochemistry and Brain Functional Connectivity: Therapeutic Potential for Substance Use Disorder and Psychiatric Disorders" Grand Rounds, Department of Psychiatry, Harvard University
"Preaddiction Phenotype is Associated with Dopaminergic Dysfunction: Pharmacogenomic Evidence from 88.8M GWAS-Based Samples." 2024. NIDA Genetics Conference, May 23-24, Bethesda, MD.
"The Influence of Tetrahydrocannabinol on Skeletal Development over Multiple Life Stages" ORS 2025 Conference
"The role of Fatty Acid Binding Protein in Psychiatric Disorders" Seminar, Department of Biology, National and Kapodistrian University of Athens

Service Activities:

Poster reviewer for annual conference of CSTEP since 2017; Poster Reviewer (2022)
Assisted with Poster review on research day of CRIA, 2016-2020; Poster reviewer (2022)
Participated in annual conference with presentation and meet with students; Assisted with planning meetings and faculty member of the Ingestive Behavior Center at UB (2022–2025)
faculty member, will assist with future conference; faculty member of the UB CeCaR. (2022–2025)
Will review and delegate reviews on papers in the area of psychopharmacology; Section Editor, Current Pharmaceutical Design (2021–2026)
Reviewer of manuscripts in my area of expertise; member of the Editorial Board Journal of Precision Medicine (2021–2027)
Section editor for Behavioral Pharmacology in the journal Current Psychopharmacology; Section Editor (2020–2026)
Admissions; Member (2018–present)
Curriculum; Coordinator (2017–present)
2024. University at Buffalo. Department of Exercise and Nutrition Sciences. Exercise Effects on Behavior, Neurochemistry and Brain Functional Connectivity.; Invited Speaker
National Institute of Mental Health Special Emphasis Panel. NATIONAL INSTITUTE OF MENTAL HEALTH. ZMH1 ERB-P (06). BRAIN Initiative F32 Special Emphasis Panel, 2024; NIH Study section Grant Reviewer Member

Panayotis Thanos PhD

Panayotis Thanos
PhD

Specialty/Research Focus

Professional Summary:

Education and Training:

Employment:

Awards and Honors:

Research Expertise:

Grants and Sponsored Research:

Journal Articles:

Professional Memberships:

Presentations:

Service Activities:

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

PhD Program in Biomedical Sciences

Connect With Us

Jacobs School of Medicine and Biomedical Sciences

About The School

Education and Training

Centers and Affiliations

Find People

Resources by Audience

Alumni and Friends

Research Facilities and Services

Get Involved

Learning Resources

Support Services

Site Tools